Regulus Therapeutics Inc

NASDAQ:RGLS   1:52:28 PM EDT
0.39
-0.03 (-6.18%)
Earnings Announcements

Regulus Therapeutics Posts Q3 Loss Per Share Of $0.10

Published: 11/10/2021 22:23 GMT
Regulus Therapeutics Inc (RGLS) - Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates.
Q3 Loss per Share $0.10.
Revenue is expected to be $0.01 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.